These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1950448)

  • 1. Psychotic complications of long-term levodopa treatment of Parkinson's disease.
    Friedman A; Sienkiewicz J
    Acta Neurol Scand; 1991 Aug; 84(2):111-3. PubMed ID: 1950448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central side effects of long-term treatment of Parkinson disease with levodopa preparations].
    Friedman A; Sienkiewicz J
    Neurol Neurochir Pol; 1991; 25(4):449-54. PubMed ID: 1803254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Old-onset Parkinson's disease compared with young-onset disease: clinical differences and similarities.
    Friedman A
    Acta Neurol Scand; 1994 Apr; 89(4):258-61. PubMed ID: 8042442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugate eye deviations as dyskinesias induced by levodopa in Parkinson's disease.
    LeWitt PA
    Mov Disord; 1998 Jul; 13(4):731-4. PubMed ID: 9686783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of delusional jealousy in Parkinson disease ].
    Brüne M; Gerlach G; Schröder SG
    Nervenarzt; 2001 Mar; 72(3):224-6. PubMed ID: 11268767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa-induced psychosis: a kindling phenomenon.
    Moskovitz C; Moses H; Klawans HL
    Am J Psychiatry; 1978 Jun; 135(6):669-75. PubMed ID: 655276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
    Horstink MW; Zijlmans JC; Pasman JW; Berger HJ; van't Hof MA
    J Neurol Neurosurg Psychiatry; 1990 Mar; 53(3):224-6. PubMed ID: 2324754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
    Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
    Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic dilemma: psychosis and Parkinson's disease.
    Damecour CL; Turcotte JR
    Can J Psychiatry; 1995 Dec; 40(10):640-1. PubMed ID: 8681265
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychotic symptoms in Parkinson’s disease.
    Henrichsmann M
    Med Monatsschr Pharm; 2016 Jul; 39(7):293-5. PubMed ID: 29953182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychotic complications of long term levodopa treatment of Parkinson's disease.
    Rampello L; Raffaele R; Furnari P; Vecchio I; Malaguarnera M
    Arch Gerontol Geriatr; 1996; 22 Suppl 1():63-7. PubMed ID: 18653010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring motor complications in clinical trials for early Parkinson's disease.
    Marras C; Lang AE
    J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):143-6. PubMed ID: 12531932
    [No Abstract]   [Full Text] [Related]  

  • 19. Othello syndrome in patients with Parkinson's disease.
    Georgiev D; Danieli A; Ocepek L; Novak D; Zupancic-Kriznar N; Trost M; Pirtosek Z
    Psychiatr Danub; 2010 Mar; 22(1):94-8. PubMed ID: 20305599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.